How we got here: AbbVie in oncology
Our oncology story began with a focus on attacking an “unhittable” cancer target.
AbbVie SA/NV - BE-ABBV-210073 (v5.0) - July 2024
{%lSlanguageSelectorLabel%}
{%lSactiveLanguage%}AbbVie SA/NV - BE-ABBV-210073 (v5.0) - July 2024